Fiche personne


Territoire

Franche-Comté

Statut

Hospitalo-Universitaire

Projets


Publications


Combination of olaparib, durvalumab and fulvestrant in patients with advanced ER+/HER2- breast cancer and selected genomic alterations: results of the DOLAF trial.

Guiu S, Balmaña J, Lemercier P, Follana P, Gonçalves A, Bigot F, Frenel JS, Brain E, Mailliez A, Chakiba Brugere C, Curtit E, Derbel O, Dalenc F, Derquin F, Duhoux F, Canon JL, Pimentel I, Chevalier LM, Buisson A, Guyonneau C, Lemonnier J, Delaloge S, Bachelot T

Clin Cancer Res. 2025 09 23;:

Retrospective comprehensive analysis of regional lymph node recurrence in breast cancer patients (REASON study).

Liapi A, Aedo-Lopez V, Jeanneret-Sozzi W, Stravodimou A, Prior JO, Lalonde MN, Treboux AI, Lelievre L, Kandalaft L, Rossier L, Goupil A, Bergomi M, Rivals JP, Brouland JP, Curtit E, Meuwly JY, Zaman K

J Cancer Res Clin Oncol. 2025 05 29;151(5):176

Voir plus